Plasse TF, Delgado B, Potts J, Abramson D, et al. Randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19. Int J Infect Dis 2022 Dec 19:S1201-9712(22)00638.
PMID: 36549549